- Multimodal Treatment Strategies in Esophagogastric Junction Cancer: a Western Perspective
-
Goetze TO, Al-Batran , Berlth F, Hoelscher
- KMID: 2449935
- J Gastric Cancer.
- 2019 Jun;19(2):148-156.
- doi: 10.5230/jgc.2019.19.e19
Esophagogastric junction (EGJ) cancer is a solid tumor entity with rapidly increasing incidence in the Western countries. Given the high proportion of advanced cancers in the West, treatment strategies routinely... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data
-
Fuchs CS, Muro K, Tomasek J, Van Cutsem E, Cho JY, Oh SC, Safran H, Bodoky G, Chau I, Shimada Y, Al-Batran , Passalacqua R, Ohtsu A, Emig M, Ferry D, Chandrawansa K, Hsu Y, Sashegyi A, Liepa AM, Wilke H
- KMID: 2383736
- J Gastric Cancer.
- 2017 Jun;17(2):132-144.
- doi: 10.5230/jgc.2017.17.e16
PURPOSE: To identify baseline prognostic factors for survival in patients with disease progression, during or after chemotherapy for the treatment of advanced gastric or gastroesophageal junction (GEJ) cancer. MATERIALS AND METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
